Birchview Capital’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,005
Closed -$22K 56
2023
Q1
$22K Hold
4,005
0.02% 55
2022
Q4
$20K Hold
4,005
0.01% 56
2022
Q3
$22K Sell
4,005
-1,535
-28% -$16.5K 0.02% 60
2022
Q2
$49K Sell
5,540
-1,334
-19% -$13.5K 0.04% 58
2022
Q1
$107K Hold
6,874
0.08% 58
2021
Q4
$182K Hold
6,874
0.12% 61
2021
Q3
$335K Hold
6,874
0.23% 52
2021
Q2
$579K Hold
6,874
0.35% 42
2021
Q1
$696K Sell
6,874
-49,133
-88% -$5.4M 0.41% 36
2020
Q4
$5.62M Sell
56,007
-150,000
-73% -$10M 3.24% 7
2020
Q3
$9.51M Sell
206,007
-13,809
-6% -$709K 6.36% 4
2020
Q2
$12.7M Buy
+219,816
New +$14.7M 7.65% 3

Other funds holding AWH

Birchview Capital's AWH Position: Q2 2023 in Review

Birchview Capital sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2023, closing a stake of 4,005 shares — an estimated $22K sold.

Birchview Capital first reported a position in AWH in Q2 2020 and held it in 12 quarters. The position peaked at $12.7M in Q2 2020. 22 funds tracked by Wall St. Rank hold AWH as of Q2 2023.

  • Birchview Capital reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Birchview Capital sold 4,005 Aspira Women's Health Inc. Common Stock shares in Q2 2023, an estimated $22K.
  • Birchview Capital first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Birchview Capital's Aspira Women's Health Inc. Common Stock position peaked at $12.7M in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2023.

Based on Birchview Capital's 13F filing for Q2 2023, filed 8 Aug 2023.